BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1654363)

  • 1. Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
    MacGregor RR; Graziani AL; Weiss R; Grunwald JE; Gambertoglio JG
    J Infect Dis; 1991 Oct; 164(4):785-7. PubMed ID: 1654363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foscarnet.
    Med Lett Drugs Ther; 1992 Jan; 34(861):3-4. PubMed ID: 1309469
    [No Abstract]   [Full Text] [Related]  

  • 3. Foscarnet sodium.
    Minor JR; Baltz JK
    DICP; 1991 Jan; 25(1):41-7. PubMed ID: 1848959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Drew WL; Feinberg J; O'Donnell JJ; Whitmore PV; Miner RD; Parenti D
    J Infect Dis; 1991 Jun; 163(6):1348-51. PubMed ID: 1645385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seeing the way forward for treatment of CMV retinitis.
    Lancet; 1991 Dec; 338(8781):1494-5. PubMed ID: 1683924
    [No Abstract]   [Full Text] [Related]  

  • 6. Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet.
    Jacobson MA; O'Donnell JJ
    J Acquir Immune Defic Syndr (1988); 1991; 4 Suppl 1():S11-5. PubMed ID: 1848616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet.
    Jacobson MA
    Am J Med; 1992 Feb; 92(2A):26S-29S. PubMed ID: 1310573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
    Farese RV; Schambelan M; Hollander H; Stringari S; Jacobson MA
    Ann Intern Med; 1990 Jun; 112(12):955-6. PubMed ID: 2160217
    [No Abstract]   [Full Text] [Related]  

  • 9. Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome.
    Polis MA
    Am J Med; 1992 Feb; 92(2A):22S-25S. PubMed ID: 1310572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis.
    Aweeka F; Gambertoglio J; Mills J; Jacobson MA
    Antimicrob Agents Chemother; 1989 May; 33(5):742-5. PubMed ID: 2546491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.
    Chrisp P; Clissold SP
    Drugs; 1991 Jan; 41(1):104-29. PubMed ID: 1706982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.
    Palestine AG; Polis MA; De Smet MD; Baird BF; Falloon J; Kovacs JA; Davey RT; Zurlo JJ; Zunich KM; Davis M
    Ann Intern Med; 1991 Nov; 115(9):665-73. PubMed ID: 1656826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of CMV retinitis.
    Morris DJ
    Lancet; 1992 Jan; 339(8787):247. PubMed ID: 1346202
    [No Abstract]   [Full Text] [Related]  

  • 14. Foscarnet for CMV retinitis.
    Wood CA
    Lancet; 1992 Feb; 339(8791):501. PubMed ID: 1346861
    [No Abstract]   [Full Text] [Related]  

  • 15. Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens.
    Katlama C; Dohin E; Caumes E; Cochereau-Massin I; Brancon C; Robinet M; Rogeaux O; Dahan R; Gentilini M
    J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S18-24. PubMed ID: 1318363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of cytomegalovirus retinitis.
    Henderly DE; Jampol LM
    J Acquir Immune Defic Syndr (1988); 1991; 4 Suppl 1():S6-10. PubMed ID: 1848624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Jacobson MA; O'Donnell JJ; Mills J
    Antimicrob Agents Chemother; 1989 May; 33(5):736-41. PubMed ID: 2546490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).
    Walmsley SL; Chew E; Read SE; Vellend H; Salit I; Rachlis A; Fanning MM
    J Infect Dis; 1988 Mar; 157(3):569-72. PubMed ID: 2830347
    [No Abstract]   [Full Text] [Related]  

  • 19. Foscarnet approved for cytomegalovirus retinitis.
    Am Fam Physician; 1991 Nov; 44(5):1890. PubMed ID: 1659165
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of CMV retinitis.
    Deray G; Katlama C; Jacobs C
    N Engl J Med; 1992 Jun; 326(25):1702. PubMed ID: 1317011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.